ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,488.46
1.13%
US Tech 100
18,637.20
0.55%
Dow Jones
40,415.00
1.41%
Brent Oil
81.315
0.72%
Bitcoin
64,989.21
-0.58%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) News

VRDN

Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VRDN
DateTimeSourceHeadlineSymbolCompany
07/25/20248:00AMBusiness WireViridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)NASDAQ:VRDNViridian Therapeutics Inc
07/15/20246:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRDNViridian Therapeutics Inc
07/03/20248:00AMBusiness WireViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
06/11/20246:00AMBusiness WireViridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye DiseaseNASDAQ:VRDNViridian Therapeutics Inc
06/10/20248:05AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VRDNViridian Therapeutics Inc
06/06/20244:01PMBusiness WireViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
05/31/20248:00AMBusiness WireViridian Therapeutics Announces Participation in Upcoming June Investor ConferencesNASDAQ:VRDNViridian Therapeutics Inc
05/10/20248:00AMBusiness WireViridian Therapeutics to Participate in Upcoming May Investor ConferencesNASDAQ:VRDNViridian Therapeutics Inc
05/08/20247:51AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRDNViridian Therapeutics Inc
05/08/20247:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRDNViridian Therapeutics Inc
05/08/20247:00AMBusiness WireViridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial ResultsNASDAQ:VRDNViridian Therapeutics Inc
05/03/20248:00AMBusiness WireViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
04/29/20248:00AMBusiness WireViridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024NASDAQ:VRDNViridian Therapeutics Inc
04/04/20244:01PMBusiness WireViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
03/06/20244:01PMBusiness WireViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
03/05/20248:00AMBusiness WireViridian Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:VRDNViridian Therapeutics Inc
02/28/20244:10PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRDNViridian Therapeutics Inc
02/27/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRDNViridian Therapeutics Inc
02/27/20244:01PMBusiness WireViridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:VRDNViridian Therapeutics Inc
02/16/20248:00AMBusiness WireViridian Therapeutics Appoints Jennifer Tousignant as Chief Legal OfficerNASDAQ:VRDNViridian Therapeutics Inc
02/14/20248:28PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VRDNViridian Therapeutics Inc
02/14/20244:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VRDNViridian Therapeutics Inc
02/14/20244:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VRDNViridian Therapeutics Inc
02/14/20244:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VRDNViridian Therapeutics Inc
02/14/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRDNViridian Therapeutics Inc
02/14/20249:01AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VRDNViridian Therapeutics Inc
02/07/20244:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRDNViridian Therapeutics Inc
02/06/20244:01PMBusiness WireViridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
01/24/20246:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRDNViridian Therapeutics Inc
01/24/20245:12PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VRDNViridian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VRDN

Your Recent History

NASDAQ
NVDA
NVIDIA
NASDAQ
MULN
Mullen Automotive
NASDAQ
COOP
Mr Cooper
USOTC
SAPX
Seven Arts Entertainment (PK)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
ECSL
Ecare Solutions (PK)
NASDAQ
TSLA
Tesla
USOTC
BLEG
Branded Legacy (PK)
USOTC
RDGL
Vivos (QB)
USOTC
ITUP
Interups (CE)
USOTC
RONN
Ronn Motor (PK)
COIN
XRPUSD
Ripple
USOTC
RXMD
Progressive Care (QB)
NASDAQ
NB
NioCorp Developments
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved